Dr. Pritesh Kumar is the Managing Director of PhytoSciences GmbH, a Switzerland based consultancy comprising scientists & analysts across the EU, Africa, Canada, India, and USA. Dr. Kumar has a diverse set of skills and experiences in the fields of structuring & commercializing science assets, risk advisory, and investment due diligence. Dr. Kumar holds a Ph.D. in Pharmacology and Toxicology, with a focus in cannabinoid (cannabis) pharmacology, from the University of Louisville, School of Medicine.

Dr. Kumar has provided consulting services to several U.S. state government officials as well as international governments and policy officials on effective medical cannabis policies. He regularly advises on laboratory facility design / optimization, cannabis testing equipment, analytical methodology for cannabinoid analysis and separation, pharmacology of cannabis-based therapeutics and maintaining a QA system to ensure compliance, including preparation of legislative documents to regulate a QA system with regard to cannabis manufacturing and processing.

He has received numerous honors and awards including Best Oral Presentation from the International Cannabinoid Research Society (ICRS) Conference in Vancouver and fellowships from Drug Discovery and Target in Boston and Integrated Programs in Biomedical Sciences (IPIBS) as well as travel awards from the National Institute on Drug Abuse for his presentations in Canada, Switzerland, Italy, USA, and Germany.